Abstract. Oleuropein could inhibit growth and/or induce apoptosis in several cancer cell lines. In this study, we investigate how oleuropein strongly induces apoptotic cell death in HeLa human cervical carcinoma cells. Oleuropein induced HeLa cells apoptosis as demonstrated by induction of a sub-G 1 peak in flow cytometry and apoptosis-related morphological changes observed by fluorescence microscopy after being stained by Hoechst 33324. The results also showed that 150 -200 mM oleuropein-treated HeLa cells were arrested at the G 2 /M phase. Western blot analysis revealed that the phosphorylated ATF-2, c-Jun NH 2 -terminal kinase (JNK) protein, p53, p21, Bax, and cytochrome c protein in the cytoplasm significantly increased in a dose-dependent manner after treatment of oleuropein for 24 h. Additionally, increasing levels of Bax in response to JNK/SPAK signaling, which formed mitochondrial membrane channels, accounted for releasing of cytochrome c and activation of caspase-9 and -3. SP600125 (20 mM), a JNK 1/2 inhibitor, markedly suppressed the formation of apoptotic bodies and JNK activation induced by oleuropein at 200 mM. Thus, oleuropein-induced apoptosis was activated by the JNK/SPAK signal pathway. The result shows that oleuropein holds promise as a potential chemotherapeutic agent for the treatment of HeLa cells.
Introduction
Oleuropein belongs to the secoiridoids, a group of coumarin-like compounds (1) . It is also the most general prominent phenolic compound in Olea europaea L. products such as olives, olive oil, and olive leaves (2) . Recently, more scientific interests have been focused on the association between the olive phenols and human health. Indeed, olive phenols such as oleuropein possess several positive functions for human health, including having antioxidant (3), antiinflammatory (4), antimicrobial (5, 6), antiviral (7, 8) , and neuroprotective activity (9) . Additionally, Olea europaea extract inhibits proliferation in a variety of cancer cell lines, such as human colon adenocarcinoma cells Caco-2 (10), human glioblastoma cells T98G (11) , melanoma cells B16 (12) , human lymphoblastic cell line Jurkat (13) , human adenocarcinoma cells HT115 (14) , human fetal lung cells MRC-5 (14) , and human leukemia cells HL-60 (15) . Notably, recent studies have shown that oleuropein inhibits growth and induces apoptosis in human breast cancer cells MCF-7 (16) , prostate cancer cell lines LNCaP, DU145 (17) and human lung carcinoma A549 cells (18) . Here, we demonstrate whether oluropein exhibits the same apoptotic cell death effect in human cervical carcinoma HeLa cells.
The c-Jun N-terminal protein kinase (JNK) plays a key role in death receptor-initiated extrinsic as well as mitochondrial intrinsic apoptotic pathways. In the later case, JNK phosphorylates Bim and Bmf, and then the two activate Bax (19, 20 as cytochrome c which can be released (21 -23) . Subsequently, cytochrome c can bind caspase-9 and Apaf-1, thereby promoting apoptosis (24) . JNK can also regulate c-Jun through phosphorylating specific serines (63 and 73) of c-Jun protein (25) . Additionally, c-Jun is a central component of activator protein 1 (AP-1), which consists of Jun (c-Jun, Jun B, and Jun D), Fos (c-Fos, FosB, Fra-1, and Fra-2), and ATF (ATF2, LRF1/ATF3, and B-ATF). AP-1 controls cell life and death through regulating the expression and function of cell cycle regulators such as Cyclin D1, p53, p21cip1/waf1, p19ARF, and p16 (26) . Many results suggest that c-Jun is required for transit beyond the G 1 /S interphase by a mechanism that involves direct transcriptional control of the cyclin D1 gene (27, 28) . c-Jun is also a mediator of the aberrant cyclin A2 expression associated with Ras/Src-induced transformation (29) . It was shown that cyclin A2 could overcome the G 1 arrest in rat liver oval cells (30) . Genipin could induce G 2 /M and apoptosis associated with activation of the c-Jun NH 2 -terminal kinase in HeLa cells (31) . The tumor suppressor and transcription factor p53 is a key modulator of cellular stress responses, and activation of p53 can trigger apoptosis in many cell types (32) . P53 plays an important role in regulating the G 2 /M transition. Progression from G 2 into mitosis was blocked when p53 was overexpressed in human fibroblasts (33) . Hence, we investigated the effect of oleuropein on HeLa cells proliferation, cell cycle, and apoptosis with a preliminary understanding of its plausible mechanism of action. The results showed that oleuropein induces apoptosis via mitochondrial intrinsic apoptotic pathway through activating JNK in HeLa cells. When the concentration of oleuropein was over 150 mM, in HeLa cells, there was a blockage of cell cycle progression at the G 2 /M phase in response to expression of p53.
Materials and Methods

Materials and cell culture
Oleuropein (99.9% by HPLC) was purchased from PUSH Biotechnology, Ltd. (Chengdu, China) and dissolved in DMSO at 27 mg/mL as a stock solution. Antibodies anti-phosphor-ATF-2, anti-b-actin, antiphosphor-p38MAPK, anti-cytochrome c, anti-cleaved poly ADP-ribose-polymerase (PARP), anti-Bcl-2, antiphosphor-JNK, and anti-phos-phor-c-Jun were obtained from Cell Signal Technology (Beverly, MA, USA). Bax antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Caspase-9 and Caspase-3 Activity Kits were acquired from Beyotime Institute of Biotechnology (Suzhou, China). The mitochondrial fractionation kit was purchased from Sangon Bitotech Co., Ltd.
(Shanghai, China). Peroxidase-conjugated Affini Pure goat anti-rabbit immunoglobulin was from ZSGB-BIO Co., Ltd. (Beijing, China). PVDF paper and the enhanced chemiluminescence (ECL) western blot detection system were purchased from Millipore Co. (Billerica, MA, USA). Triton X-100, Tris base, SDS, acrylamide, bisacrylamide, and ammonium persulfate were from Amresco Co. (Solon, OH, USA). All stock solutions were stored at 4°C or −20°C. All other chemicals were of analytical grade.
MCF-7, H1299, and HeLa cells were from the transplantation and immunization lab., West China Hospital of Sichuan University (China). These cells were maintained at 37°C in humidified air atmosphere with 5% CO 2 and cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS, HyClone, China), and antibiotics (100 units/ml of penicillin and 100 mg/ml of streptomycin) (Solarbio, Beijing, China). For treatment, the cells were trypsinized and seeded at a density of about 2 × 10 5 cells/ml per flask. All experiments were performed in plastic tissue culture flasks, dishes, or plates (34) .
Cell number assay
The cells were seeded at a density of 0.8 × 106 per 100 mm plastic dish. Then the cells were treated with different concentrations of oleuropein (at 0, 100, 200 mg/ml) for 24 h. At the end of the incubation period, cells were trypsinized and total cell number was counted by a hemocytometer.
Morphological observation of cells
After being cultured at 37°C for 24 h in 6-well plates, MCF-7, H1299, and HeLa cells were treated with various concentrations of oleuropein (0, 100, and 200 mM) for 24 h. The cells were observed with an inverted microscope.
Hoechst 33258 staining
For fluorescence observation, HeLa cells treated with 200 mM oleuropein were visualized by Hoechst 33258 staining following the use of the Apoptotic body/Nuclear DNA Staining Kit (Bio Basic Inc., Markham, Ontario, Canada). Briefly, HeLa cells were cultured in 6-well plates for 24 h. After treatment for 24 h with different concentrations of oleuropein (0, 50, 100, 150, and 200 mM), the cells were washed with PBS, fixed in 10% formaldehyde solution for 5 min at room temperature, and resuspended in 50 mL of PBS before deposition on coverslips. The adhered cells were incubated with Hoechst 33258 for 20 min at room temperature (35) . Coverslips were rinsed with PBS and imaged by fluorescence microscopy (LWD200-37FT; Shanghai Cewei Guangdian Jishu Inc., Shangai, China).
Western blot analysis
For detection of various proteins, the untreated and oleuropein-treated whole-cell extracts were lysed in lysis buffer (250 mM NaCl, 10 mM Tris, pH 7.4, 1 mM ethylene diamine tetraacetic acid (EDTA), 1% Triton X-100, 1 mM phenylmethanesulfonyl fluoride (PMSF), 0.01 mg/ml aprotinin, and 0.01 mg/ml leupeptin). Whole cell lysates were clarified by centrifugation at 12,000 × g for 10 min at 4°C (36) . The amounts of protein were normalized by the Bradford method (31) . Equal amounts of total proteins were loaded to 10% -15% SDS-PAGE gels and subsequently transferred on to PVDF membranes. After electro-transfer, membranes were blocked with 5% nonfat milk in TSB-T buffer (100 mM Tris-HCl, pH 7.5, 0.9% NaCl, 0.05% Tween-20), probed with various primary antibodies (1:1000) overnight at 4°C, and anti-rabbit IgG for 1 h. Then photographs were taken with the Bio-Rad ChemiDoc XRS imager with the ECL Western blot detection system and analyzed using Quantity One software (Bio-Rad, Hercules, CA, USA).
Analysis of cytochrome c release
For mitochondrial cytochrome c release assay, a mitochondrial fractionation kit was used to separate mitochondrial and cytosolic fractions according to manufacturer's protocols. Ten million cells resuspended with ice-cold Mito-cyto isolation buffer and homogenized 50 times. Homogenate was centrifuged at 3,000 rpm for 10 min at 4°C. The supernatants were collected in a new ice-cold tube and then centrifuged at 12,000 rpm for 30 min at 4°C. The supernatant and pellet were saved as the cytosolic fraction and intact mitochondria, respectively. Before western blot analysis of cytosolic fraction was performed, protein concentration was measured after fractionation.
Cytosolic and nuclear protein extraction
Following treatment of cells with oleuropein (0, 50, 100, 150, and 200 mM, for 24 h), the cells were washed twice with PBS (10 mM, pH 7.4). The cells were incubated in 0.2 mL ice-cold lysis buffer [10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mM PMSF] for 15 min, after which 12.5 mL of 10% Nonidet P-40 was added and the contents were mixed on a vortex and then centrifuged for 1 min (14,000 g) at 4°C. The supernatant was saved as cytosolic lysate and stored at −80°C. The nuclear pellet was resuspended in 50 mL of ice-cold nuclear extraction buffer [20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF] for 30 min with intermittent mixing. The tubes were centrifuged for 5 min (14,000 g) at 4°C, and the supernatant (nuclear extract) was stored at −80°C.
Caspase activity
The activities of caspase-9 and -3 were measured using the Caspase Activity Kit according to the manufacturer's instructions. Briefly, supernatants from cell lysates treated with 200 mM oleuropein were incubated at 37°C with Ac-LETD-rNAor Ac-DEVD-rNA in a reaction buffer for 2 h. The release of rNA was qualified by determining the absorbance at 405 nm using a spectrophotometer. The enzymatic activity is represented as DA405/(min·mg protein).
Cell cycle analysis
For cell cycle and apoptosis analysis by flow cytometry, cells were treated with different concentrations of oleuropein for 24 h. Cells were then harvested and washed twice with ice-cold PBS. The cells were fixed with 70% ethanol at 4°C overnight and treated with propidium iodide (PI, 50 mg/ml) and RNase A (100 mg/ml) at 37°C for 40 min, and then the samples were analyzed by flow cytometry (FACS calibur; BD Biosciences, San Jose, CA, USA). The sub-G 1 population was scored from hypodiploid DNA content. Data were analyzed using ModFit LT V3.2 software.
Inhibitor assay
To investigate the effect of mitogen-activated protein kinases (MAPK) inhibitors on oleuropein-induced cell cycle arrest and apoptosis, HeLa cells were cultured with JNK inhibitor (20 mM SP600125) for 2 h. Then 200 mM oleuropein was added for the indicated time periods.
Statistical analysis
All data were presented as the mean ± S.D. of at least 3 independent experiments. One-way analysis of variance (ANOVA) was used for multiple comparison followed by Dunnett's test or the Bonferroni test. A probability value less than 0.05 was considered statistically significant.
Results
Morphology changes in oleuropein-treated cancer cells
The cytotoxic effect of oleuropein was evaluated after MCF-7, H1299, and HeLa cells were treated with the indicated concentrations of oleuropein (at 100, 200 mM) for 24 h and then observed the morphology changes under a microscope. The numbers of the 3 types of cells in declined. Especially, we clearly observed that HeLa cells exhibited the characteristic features of apoptosis such as cell shrinkage, membrane blebbing, and the appearance of apoptotic bodies (Fig. 1) , while the untreated control cells showed normal features with round and homogeneous nuclei. Thereby, the morphology changes induced by oleuropein in HeLa cells were more significant than those in the other two types. With the increasing oleuropein, the number of shrunken cells increased in a dose-dependent manner. In addition, the exposure of HeLa cells to 200 mM oleuropein resulted in the most remarkable apoptotic phenomena. The IC 50 of oleuropein in HeLa cells was 157.5 mM, so further experiments were conducted on HeLa cells exposed to 200 mM olueropein according to the specific experiment.
Effect of oleuropein on apoptosis and the induction of G 2 /M cell cycle arrest in HeLa cells
Cell cycle distribution and apoptosis were examined to investigate the mechanism associated with oleuropeininduced anti-proliferation. Cells were treated with different concentrations of oleuropein for 24 h and then harvested for cell cycle analysis by flow cytometry after PI staining. As shown in Fig. 2A , the percentage of cells in the G 2 /M phase changed from 14.99% in the control cells to 7.89, 12.81, 21.37, and 22.50 in cells treated with 50, 100, 150, and 200 mM of oleuropein, respectively. With low concentration of oleuropein (at 50, 100 mM), the populations of cells in the S phase increased, compared with control cells (Fig. 2B) . On the contrary, the percentage of cells in the G 2 /M phase was lower than the control. However, with high concentration of oleuropein (150, 200 mM), G 2 /M populations significantly increased compared to that in the untreated cells. G 2 /M arrest appeared while the concentration of oleuropein was over 150 mM.
Apoptotic cells are assumed to contain more hypodiploid DNA, which presents as a sub-G 1 peak in flow cytometry (37) . Treatment with oleuropein for 24 h resulted in a significant increase in the accumulation of sub-G 1 cells from 0.5% to 19.67% in a dose-dependent manner (Fig. 2C) . Additionally, by using the PARP cleavage assay, we further found that the cytotoxicity was due to apoptosis. The amount of cleaved-PARP protein significantly increased to about 3-fold with the treatment of 200 mM oleurpein (Fig. 2D ). These results demonstrate that the cytotoxicity in oleuropein-treated HeLa cells is due to apoptosis.
Activation of JNK pathway and expression of p53 in oleuropein-treated HeLa cells
To investigate a plausible involvement of a signaling pathway in oleuropein-induced apoptosis, we examined the activation status of JNK, p38MAPK, and NF-kB by western blotting with antibodies specific to the phosphorylated forms of theses kinases. Treatment of cells with oleuropein resulted in a notable dose-dependent increase of phosphorylated JNK, indicating the activation of JNK in HeLa cells (Fig. 3) . In contrast, significant regular changes of p38MAPK, I-kB (in cytoplasm), and NF-kB (in nucleus) could not be observed in HeLa cells treated with oleuropein compared with the control treatment (Fig. 4) . Futhermore, expression of p53, p-p53, and p21 protein gradually increased and reached a peak at 200 mM during the period of treatment of oleuropein as well as p-JNK (Fig. 5) . Moreover, phosphorylation of c-Jun, a major target of JNK, which is a signal of JNK activation (26) , as well as p-ATF-2 was increased upon oleuropein treatment. In addition, the levels of p-JNK, p-c-Jun, p53, and cleaved-PARP protein in cells preincubated for 2 h with 20 mM SP600125 (JNK inhibitor) decreased significantly, compared with the ones that were only cultured with 200 mM oleuropein (Fig. 6A) .
Nuclear fragmentation in HeLa cells treated for 24 h with various concentrations of oleuropein was determined by Hoechst 33258 staining (Fig. 6B ). Apoptotic bodies containing nuclear fragments were found only in oleuropein-treated cells; the nuclear envelope appeared lytic and the cytoplasm had shrunk. In contrast, the JNK inhibitor SP600125 notably suppressed the formation of clearly visible apoptotic bodies in 200 mM oleuropein-treated cells. The cells cultured with oleuropein and SP600125 showed normal cell nuclei morphology as in the control. These results showed the JNK signaling pathway mediated the oleurepein-induced apoptosis in HeLa cells.
Oleuropein induces apoptosis through the mitochondrial cellular execution pathway
Signaling pathways that initiate apoptosis have been broadly classified into 1) extrinsic pathways initiated by death receptors, such as those of tumor necrosis factor (TNF)-a, TRAIL, and fas ligand (FAS-L), and 2) intrinsic pathways initiated by mitochondrial events (38) .
To evaluate the contribution of the mitochondrial pathway to the induction of apoptosis by oleuropein, we examined Bax, Bcl-2, and cytochrome c by western blotting and caspase-9, caspase-3 by using the Caspase Activity Kit. As shown in Fig. 6 , oleuropein upregulated the expression of pro-apoptotic protein Bax and downregulated the anti-apoptotic protein Bcl-2. There was a dose-dependent increase in Bax/Bcl-2 ratio (Fig. 7A) . The Bcl-2 family can form membrane channels of mitochondria. The subcellularly located cytochrome c, Fig. 3 . Oleuropein activates the JNK pathway in HeLa cells. Cells were treated with different concentration of oleuropein for 24 h, and then whole cell lysates were subjected to western blotting using antibodies specific to phosphorylated forms of ATF-2, p-JNK, p-c-Jun, and p38MAPK. Data are means ± S.D. of 3 independent experiments. *P < 0.05 and **P < 0.01 vs. control (ANOVA with Dunnett's multiple comparison test). Fig. 4 . After oleuropein treatment, there was no regularity changes in the NF-kB and p-p38MAPK pathway in HeLa cells. Cells were treated with different concentrations of oleuropein for 24 h. Then whole cell lysates, nuclear protein extracts, and cytosolic protein extracts were subjected to western blotting using antibodies specific to phosphorylated forms of p38MAPK, NF-kB, and I-kB respectively. Data are means ± S.D. of 3 independent experiments. *P < 0.05 and **P < 0.01 vs. control (ANOVA with Dunnett's multiple comparison test).
which normally resides in the mitochondria, is released into the cytoplasm following exposure of cells to certain apoptotic stimuli. It has been suggested to participate in activating the cell death process (39) . We observed that cytochrome c in the cytosolic fraction increased significantly in a dose-dependent manner (Fig. 7A) . These results showed that oleuropein-induced apoptosis resulted in cytochrome c release from the mitochondria into the cytosol in HeLa cells.
Subsequently, we examined the activities of caspase-9 and -3 followed by the release of cytochrome c into the cytosol (Fig. 7C) . Data from a time kinetic study of caspases indicated that caspase-9 and -3 were activated upon oleuropein treatment. It was shown that oleuropein induced a significant increase in caspase-9 activity, approximately from 1.0-fold at 2 h to 2.5-fold at 4 h, and the activity of caspase-3 also substantially increased 2.2-fold of that in the control group at 8 h, respectively. Interestingly, the activity of caspase-3 peaked at 8 h later than caspase-9. The caspase-9 peaked at 4 h. Thereby, activated caspase-9 acted on caspase-3. Then, caspase-3 was activated and promoted apoptosis.
To confirm the upregulation of Bax, downregulation of Bcl-2, and the cytochrome c release were in response to JNK activation, we used the JNK inhibitor SP600125. As shown in Fig. 7B , inhibition of JNK by pretreatment with SP600125 effectively reduced the protein level of cytochrome c. Besides, the pretreatment of JNK markedly diminished oleuropein-evoked the upregulation of Bax when cells were treated for 24 h and 48 h (Fig. 8) . Taken together, these data suggest that oleuropein induces apoptosis through the mitochondrial cellular execution pathway.
Discussion
In recent years, oleuropein, used as the main component of a phenolic mixture coming from olive leaves or extra virgin olive oil, has shown antiproliferative effects against some cancer cell lines, such as T98G, Caco-2, and MCF-7 in vitro (10, 11, 16) . Oleuropein also can regress tumors in mice (40) . In our study, oleuropein inhibits growth in MCF-7, H1299, and HeLa cells (Fig. 1) . Then HeLa was mainly adopted to investigate the biological properties of oleuropein in our laboratory. The present study demonstrates that oleuropein, a phenolic compound, induces apoptosis in HeLa cells in a dose-dependent manner involving the activation of JNK signaling and G 2 /M arrest.
In eukaryotic cells, various MAPK pathways coordinately regulate diverse cellular activities from gene expression, mitosis, and metabolism to motility, survival, apoptosis, and differentiation (41) . MAPKs can be activated by a wide variety of different stimuli, but in general, ERKs are preferentially activated by mitogenic stimuli such as growth factors, cytokines, and phorbolesters (42 -44) , while the JNK and p38MAPK kinases are more responsible to stress stimuli ranging from oxidative stress; UV irradiation, hypoxia, an ischemia to various cytokines, including interleukin-1 (IL-1) and TNF-a (45 -48). The phosphorylation of JNK was observed in oleuropein-treated HeLa cells in our Fig. 5 . Western blot analysis of p53, p-p53, and p21 in HeLa cells induced by oleuropein. HeLa cells were treated with different concentrations of oleuropein for 24 h, and then whole cell lysates were subjected to western blotting using antibodies specific for phosphorylated forms of p53, p-p53, and p21. Data are means ± S.D. of 3 independent experiments. *P < 0.05 and **P < 0.01 vs. control (ANOVA with Dunnett's multiple comparison test).
study. JNK has been reported to participate in numerous apoptotic events. The phosphorylated JNK translocates to the nucleus where it phosphorylates and transactivates c-Jun (49, 50) . Phosphorylation of c-Jun leads to the formation of AP-1, which is involved in the transcription of a wide variety of proteins, some of them being the known proapoptotic factors (52 -54) . JNK can also phosphorylate several other transcription factors including Jun D, ATF2, ATF3, Elk-1, Elk-3, p53, RXRa, RARb, AR, NFAT4, HSF-1, and c-Myc (54) . Thus, in the context of apoptosis, the nuclear activity of JNK can potentially lead to an increase in the expression of pro-apoptotic genes and/or a decrease in the expression of pro-survival genes. In addition to the canonical nuclear signaling that leads to the upregulation of pro-apoptotic and/or downregulation of antiapoptotic genes, JNKs have an essential role in modulating the functions of pro-and antiapoptotic proteins located in the mitochondria (55, 56) .
Generally, apoptosis can be induced via two distinct intracellular signaling pathways, the death receptormediated or the mitochondrial activation-mediated pathway (38) . The mitochondrial pathway responds to anticancer drugs and multiple classes of environmental stress. During the apoptotic process, the pro-apoptotic Bcl-2 family members, such as Bax, redistribute from the cytosol to mitochondria followed by the increased membrane permeability. Due to this event, the released mitochondrial cytochrome c participates in the process leading to caspase-9 activation, followed by activation of caspase-3 (57) . Accumulation of the Bax protein was observed (Fig. 7A ) and cytochrome c content was significantly increased in the cytosol of oleuropeintreated HeLa cells, suggesting that oleuropein-induced apoptosis occurs through the mitochondrial apoptotic pathway (Fig. 7A) . Likewise, Elamin et al. have described that oleuropein induced apoptosis via the mitochondrial pathway in MCF-7 cells (58) . It has been reported that genipin induces apoptotic cell death in PC3 cells (59) and HeLa cells (35) , via JNK-dependent activation of the mitochondrial pathway. Genipin and oleuropein both belong to the large iridoid class. They have some similar biological and pharmacological activities (60) . Although other pathways may induce the mitochondrial apoptotic pathway, such as NF-kB (61), there was no regular change in oleuropein-treated HeLa cells. Moreover, inhibition of JNK using the specific inhibitor SP600125 resulted in a dramatic protection of these cells from oleuropein-induced apoptosis (Fig. 6B) , suggesting that oleuropein-induced HeLa cell death is dependent on the JNK signaling pathway that plays a critical role in inducing apoptosis. However, other reports suggest that oleuropein-induced apoptotic cell death is associated with NF-kB (58), HIF-1a (62), PI3K-Akt (17, 63) , ERK (64, 65) . Such differential effects observed from one study to another could reflect cell type or treatment specificity. The mechanism underlying such a discrepancy in different cell types remains to be investigated. However, our data provide the first evidence that oleuropein-induced apoptosis of the mitochondrial activation-mediated pathway is associated with JNK.
Perturbation of the progression of the cell cycle is a signal that can trigger apoptotic cell death. As shown in Fig. 2 , oleuropein induced accumulation of cells in the G 2 /M phase of the cell cycle, when the concentration of oleuropein was over 150 mM. However, some reports suggest that oleuropein induces G 1 arrest in several cell lines, including MCF-7, A549, and HT-29 cells (16, 18, 62) . In MCF-7, olive leaves extract-treated cells was at G 1 arrest by the down-expression of Pin1 and c-Jun (66) . Oleuropein-induced G 2 /M arrest has been reported in BCPAP cells, while it induced a mild block in the S phase in TPC-1 cells (63) . Oleuropein in different cell lines activates different signal pathways. Then it leads to different cell-cycle phase arrests. Our data also showed that 50 mM oleuropein induced accumulation of cells in the S phase, instead of G 2 /M arrest (Fig. 2B) . The c-Jun is required for progression through the G 1 phase of the cell cycle; c-Jun-mediated G 1 progression occurs by a mechanism that involves direct transcriptional control of the cyclin D1 gene, establishing a molecular link between growth factor signaling and cell cycle regulators (67) . As the concentration of oleuropein increased, the cells gradually transited beyond the G 1 /S phase by c-Jun increasing. When the concentration of oleuropein was over 150 mM, most HeLa cells were arrested at the G 2 phase. Synchronously, there were significant increases in expression of p53, p-p53, and p21 (Fig. 5) . In 1999, Taylor et al. reported that overexpression of p53 causes G 2 arrest (68). G 2 /M delay that results from activations of p21 (69) or both p21 and p53 (70) was also found in other drug-treated tumor cells. As a cell cycle checkpoint protein, the activation of p53 might result in G 2 /M delay to allow DNA repair before replication or mitosis, through increased expression of p21. These findings may be preliminarily interpreted as the molecular mechanism of G 2 /M delay in HeLa cells induced by oleuropein. Various concentrations of oleuropein caused different perturbation of the progression of the cell cycle in HeLa cells. Additionally, p53 is one of the downstream factors of JNK signaling pathway in oleuropein-treated HeLa cells. The JNK inhibitor SP600125 also downregulated p53 (Fig. 6A) . Thus, oleuropein also regulates the cell cycle of HeLa via JNK signaling pathway.
In conclusion, a signaling pathway associated with oleuropein-induced apoptosis in HeLa cells was preliminarily examined in the present study. Treatment of HeLa cells with oleuropein resulted in G 2 /M phase cell cycle arrest and cell apoptosis in a dose-dependent manner. Additionally, the activation of JNK was shown to play a crucial role in oleuropein-induced apoptosis in HeLa cells. Upregulation of Bax and downregulation of Bcl-2 may result in cytochrome c release, which are related to the mitochondrial apoptotic pathway, respectively. These changes lead to caspase-3 activation and the ultimate induction of apoptosis in HeLa cells. Further studies will be performed on the specific apoptotic signaling pathways in oleuropein-induced apoptosis in HeLa cells. Taken together, our research provided important insights into the anticancer activity of oleuropein.
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